CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
Tag: Drugs
Opinion leaders of CD society getting together in Budapest
In the recent two weeks, Cyclolab had the pleasure to welcome two prominent pioneers of cyclodextrin research, Prof. Loftsson from
Allergic Eye treatment with Cyclodextrins
There is a not extremely recent but certainly very interesting patent application related to a special use of cyclodextrins, namely
Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
Video-class on the effect of cyclodextrins on drug permeation through membranes
Prof. Thorsteinn Loftsson (University of Iceland) explains in his lecture on the website of CyclonHit project the mechanism how drugs
Video-class on the Effects of Cyclodextrins on Drug Stability
The video of Prof. Thorsteinn Loftsson on the website of CyclonHit project gives the basic information on the effect of
Video-class on Pharmacokinetics, Toxicology and Regulatory Status of Cyclodextrins
The video of Prof. Thorsteinn Loftsson on the website of CycloHit project gives a summary on the physicochemical and pharmacokinetic
Different cyclodextrins to treat NPC
If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates
Cyclodextrins as theranostics
The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments
Advancements of CD analysis in Niemann-Pick C
Clearly, understanding the mechanism of action for cyclodextrins and consequently finding the most appropriate canditate for the treatment of Niemann